CD1C and lung adenocarcinoma: Zhao et al. [25] utilized a combination of single-cell data and bulk transcriptomic data to investigate DC-related prognostic markers in lung adenocarcinoma, identifying CD1C as a predictor of patient prognosis and immune response.